Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

1.1K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.1K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.7K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

1.6K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.6K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

1.2K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.2K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

956
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
956
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

2.3K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring the Patient Pathway to Focused Ultrasound Ablation for Essential Tremor: A Mixed-Method Approach.

Stereotactic and functional neurosurgery·2026
Same author

The study of epigenetic clocks in former professional contact sports athletes with repetitive head impacts.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

Focused Ultrasound Ablation for Neurological Disorders.

Biological psychiatry·2026
Same author

Focused ultrasound thalamotomy for essential tremor in octogenarians.

Journal of neurosurgery·2026
Same author

Complex motor imagery in elite female ice hockey players: a cortical arena of imagination revealed by magnetoencephalography.

Frontiers in human neuroscience·2026
Same author

Wearable sensor-based spinal motion assessments for identifying phenotypic clusters in chronic low back pain.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·2026

Related Experiment Video

Updated: Mar 29, 2026

Recording and Modulation of Epileptiform Activity in Rodent Brain Slices Coupled to Microelectrode Arrays
10:24

Recording and Modulation of Epileptiform Activity in Rodent Brain Slices Coupled to Microelectrode Arrays

Published on: May 15, 2018

15.5K

Neuromodulation for Epilepsy.

Vibhor Krishna1, Francesco Sammartino1, Nicholas Kon Kam King2

  • 1Division of Neurosurgery, University of Toronto, Toronto Western Hospital, 399 Bathurst Street, Toronto, Ontario M5T2S8, Canada.

Neurosurgery Clinics of North America
|November 29, 2015
PubMed
Summary
This summary is machine-generated.

Palliative neuromodulation therapies like deep brain stimulation, vagus nerve stimulation, and trigeminal nerve stimulation offer significant seizure reduction for medically intractable epilepsy. These treatments target the central and peripheral nervous systems for chronic neurostimulation.

Keywords:
Deep brain stimulation (DBS)IntractableNeurostimulationRefractory seizuresTrigeminal nerve stimulation (TNS)Vagus nerve stimulation (VNS)

More Related Videos

Using a Bipolar Electrode to Create a Temporal Lobe Epilepsy Mouse Model by Electrical Kindling of the Amygdala
09:49

Using a Bipolar Electrode to Create a Temporal Lobe Epilepsy Mouse Model by Electrical Kindling of the Amygdala

Published on: June 29, 2022

3.3K
A Cost-Effective and Minimally Invasive Protocol for Chronic Multi-Site Electroencephalography Recording in Freely Moving Mice
07:47

A Cost-Effective and Minimally Invasive Protocol for Chronic Multi-Site Electroencephalography Recording in Freely Moving Mice

Published on: October 10, 2025

635

Related Experiment Videos

Last Updated: Mar 29, 2026

Recording and Modulation of Epileptiform Activity in Rodent Brain Slices Coupled to Microelectrode Arrays
10:24

Recording and Modulation of Epileptiform Activity in Rodent Brain Slices Coupled to Microelectrode Arrays

Published on: May 15, 2018

15.5K
Using a Bipolar Electrode to Create a Temporal Lobe Epilepsy Mouse Model by Electrical Kindling of the Amygdala
09:49

Using a Bipolar Electrode to Create a Temporal Lobe Epilepsy Mouse Model by Electrical Kindling of the Amygdala

Published on: June 29, 2022

3.3K
A Cost-Effective and Minimally Invasive Protocol for Chronic Multi-Site Electroencephalography Recording in Freely Moving Mice
07:47

A Cost-Effective and Minimally Invasive Protocol for Chronic Multi-Site Electroencephalography Recording in Freely Moving Mice

Published on: October 10, 2025

635

Area of Science:

  • Neurology
  • Neurosurgery
  • Biomedical Engineering

Background:

  • Medically intractable epilepsy often requires adjunctive treatments beyond medication.
  • Neuromodulation offers a palliative approach for drug-resistant epilepsy.
  • Various central and peripheral nervous system targets have been explored for neurostimulation.

Purpose of the Study:

  • To review current palliative neuromodulation treatment modalities for intractable epilepsy.
  • To identify key neurostimulation targets and their clinical applications.
  • To summarize the efficacy of established neuromodulation therapies.

Main Methods:

  • Review of clinical trials and experimental studies on neuromodulation for epilepsy.
  • Categorization of therapies by invasiveness: anterior thalamus deep brain stimulation, vagus nerve stimulation, and trigeminal nerve stimulation.
  • Analysis of seizure frequency reduction as a primary outcome measure.

Main Results:

  • Anterior thalamus deep brain stimulation, vagus nerve stimulation, and trigeminal nerve stimulation are the main clinical modalities.
  • All reviewed neuromodulation therapies demonstrated significant reductions in seizure frequency.
  • These therapies target specific sites within the central and peripheral nervous systems.

Conclusions:

  • Neuromodulation therapies provide effective adjunctive treatment options for intractable epilepsy.
  • Established modalities like deep brain stimulation, vagus nerve stimulation, and trigeminal nerve stimulation show significant efficacy.
  • Further research continues to identify and refine neurostimulation targets for epilepsy management.